Characteristics | Clinical Status | |||
---|---|---|---|---|
ASC (35) | CAH (24) | LC (33) | HCC (19) | |
Gender | Â | Â | Â | Â |
Male n(%) | 28 (80) | 19(79.2) | 27 (81.8) | 14(73.7) |
Female n(%) | 7 (30) | 5 (20.8) | 6(18.2) | 5 (26.3) |
Age (%) | Â | Â | Â | Â |
21-39 | 11 (31.4) | 13 (54.2)a | 8 (24.2) | 3 (15.8) |
40-55 | 20 (57.1)a | 5 (20.8) | 15 (45.5) | 7 (36.8) |
56-68 | 4 (11.4) | 6 (25) | 10 (30.3) | 9 (47.4) |
ALT (IU/l), mean ± SD | 15.8 ± 3 | 34.4 ± 6 | 25.6 ± 7 | 29.4 ± 5 |
AST (IU/l), mean ± SD | 20.8 ± 7 | 42.1 ± 8 | 28.3 ± 6 | 26.5 ± 4 |
HBeAg positive(%) | 2 (5.7) | 7 (29.2)a | 5 (15.2) | 3 (15.8) |
HBeAb positive(%) | 28 (80) | 14 (58.3) | 24 (72.7) | 15 (78.9) |
HBV genotype(%) | Â | Â | Â | Â |
HBV/A | 6 (17.1) | 8 (33.3) | 4 (12.1) | 6 (31.6) |
HBV/E | 18 ((51.4) | 11 (45.8) | 21 (63.6) | 8 (42.1) |